Figure 2.
Therapeutic treatment with anti-IL23R does not affect established spondylitis and arthritis. (A) Timeline of the experiment where HLA-B27 tg rats were immunized and therapeutically treated with anti-IL23R or vehicle for 5 weeks (n = 10 and n = 7 per group, respectively). (B) Spondylitis and arthritis incidence (survival analysis). (C) Arthritis severity as measured by arthritis score and swelling of the hind paws (data are mean ± SEM).
